688399.SS
Price:
$52.95
Market Cap:
$4.44B
Jiangsu Bioperfectus Technologies Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting detectors, as well as in vitro testing services. The company was founded in 2010 and is based in Taizhou, China.
Industry
Biotechnology
IPO Date
2019-12-05
Stock Exchange
SHH
Ticker
688399.SS
According to Jiangsu Bioperfectus Technologies Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -0.88%. This represents a change of 300.52% compared to the average of -0.22% of the last 4 quarters.
The mean historical ROE of Jiangsu Bioperfectus Technologies Co., Ltd. over the last ten years is 20.14%. The current -0.88% ROE has changed -104.39% with respect to the historical average. Over the past ten years (40 quarters), 688399.SS's ROE was at its highest in in the September 2021 quarter at 21.13%. The ROE was at its lowest in in the December 2023 quarter at -6.12%.
Average
20.14%
Median
16.39%
Minimum
-10.98%
Maximum
49.24%
Discovering the peaks and valleys of Jiangsu Bioperfectus Technologies Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 500.10%
Maximum Annual ROE = 49.24%
Minimum Annual Increase = -122.69%
Minimum Annual ROE = -10.98%
Year | ROE | Change |
---|---|---|
2024 | -0.06% | -99.44% |
2023 | -10.98% | -122.69% |
2022 | 48.38% | 2.84% |
2021 | 47.04% | -4.46% |
2020 | 49.24% | 500.10% |
2019 | 8.21% | -58.33% |
2018 | 19.69% | 20.13% |
2017 | 16.39% | 393.91% |
The current ROE of Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.45%
5-year avg
26.72%
10-year avg
20.14%
Jiangsu Bioperfectus Technologies Co., Ltd.’s ROE is greater than Zhejiang Orient Gene Biotech Co., Ltd. (-8.53%), greater than Beijing Hotgen Biotech Co., Ltd. (-6.65%), greater than Daan Gene Co., Ltd. (-6.25%), less than Shanghai MicroPort Endovascular MedTech Co., Ltd. (11.51%), less than Sansure Biotech Inc. (4.14%),
Company | ROE | Market cap |
---|---|---|
-8.53% | $5.37B | |
-6.65% | $16.10B | |
-6.25% | $8.72B | |
11.51% | $11.26B | |
4.14% | $11.75B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jiangsu Bioperfectus Technologies Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jiangsu Bioperfectus Technologies Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Jiangsu Bioperfectus Technologies Co., Ltd.'s ROE?
How is the ROE calculated for Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)?
What is the highest ROE for Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)?
What is the 3-year average ROE for Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)?
What is the 5-year average ROE for Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)?
How does the current ROE for Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) compare to its historical average?